As of 2025-05-20, the Intrinsic Value of CVS Health Corp (CVS) is 103.95 USD. This CVS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 62.78 USD, the upside of CVS Health Corp is 65.60%.
The range of the Intrinsic Value is 69.18 - 172.14 USD
Based on its market price of 62.78 USD and our intrinsic valuation, CVS Health Corp (CVS) is undervalued by 65.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 69.18 - 172.14 | 103.95 | 65.6% |
| DCF (Growth 10y) | 85.54 - 199.51 | 124.19 | 97.8% |
| DCF (EBITDA 5y) | 63.92 - 107.35 | 84.20 | 34.1% |
| DCF (EBITDA 10y) | 85.99 - 146.99 | 113.27 | 80.4% |
| Fair Value | 20.91 - 20.91 | 20.91 | -66.69% |
| P/E | 84.55 - 116.61 | 99.11 | 57.9% |
| EV/EBITDA | 30.79 - 93.51 | 60.78 | -3.2% |
| EPV | 310.57 - 517.15 | 413.86 | 559.2% |
| DDM - Stable | 27.27 - 62.42 | 44.85 | -28.6% |
| DDM - Multi | 38.27 - 67.22 | 48.68 | -22.5% |
| Market Cap (mil) | 79,252.22 |
| Beta | 0.71 |
| Outstanding shares (mil) | 1,262.38 |
| Enterprise Value (mil) | 133,886.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.88% |
| Cost of Debt | 5.50% |
| WACC | 6.70% |